Colin Berry focuses on Internal medicine, Cardiology, Myocardial infarction, Heart failure and Percutaneous coronary intervention. Many of his studies on Internal medicine apply to Endocrinology as well. The study incorporates disciplines such as Surgery and Hazard ratio in addition to Cardiology.
His studies in Myocardial infarction integrate themes in fields like Interquartile range, Randomized controlled trial and Cardiac magnetic resonance imaging. His study in Heart failure is interdisciplinary in nature, drawing from both Left ventricular hypertrophy, Cardiac output, Intensive care medicine, Heart disease and Survival analysis. As a part of the same scientific study, he usually deals with the Percutaneous coronary intervention, concentrating on Thrombolysis and frequently concerns with Stent and No reflow phenomenon.
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Coronary artery disease. His work on Internal medicine is being expanded to include thematically relevant topics such as Magnetic resonance imaging. His Cardiology study combines topics from a wide range of disciplines, such as Surgery and Cardiac magnetic resonance imaging.
His work carried out in the field of Myocardial infarction brings together such families of science as Randomized controlled trial and Clinical trial. His research investigates the link between Coronary artery disease and topics such as Angina that cross with problems in Chest pain. His Fractional flow reserve research is multidisciplinary, incorporating perspectives in Stenosis and Revascularization.
Colin Berry spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Coronary artery disease. His Internal medicine research focuses on subjects like Magnetic resonance imaging, which are linked to Ventricular remodeling. His work on Ischemia, Fractional flow reserve, Coronary flow reserve and St elevation myocardial infarction as part of general Cardiology research is frequently linked to In patient, bridging the gap between disciplines.
His research in Myocardial infarction intersects with topics in Stroke, Clinical endpoint, Randomized controlled trial and Heart failure. His Percutaneous coronary intervention research incorporates themes from Artery, Surgery, Blood flow, Conventional PCI and Placebo. His Coronary artery disease research integrates issues from Microvascular angina, Angina, Quality of life, Angiography and Revascularization.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Angina and Coronary artery disease. His Internal medicine study frequently involves adjacent topics like Cardiac magnetic resonance imaging. His study connects Magnetic resonance imaging and Cardiology.
His research integrates issues of Stroke, Microcirculation and Heart failure in his study of Myocardial infarction. His Angina study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Randomized trial of preventive angioplasty in myocardial infarction.
David S. Wald;Joan K. Morris;Nicholas J. Wald;Alexander J. Chase.
The New England Journal of Medicine (2013)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
Tomasz J Guzik;Tomasz J Guzik;Saidi A Mohiddin;Anthony Dimarco;Vimal Patel.
Cardiovascular Research (2020)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif;Simon Kouz;David D. Waters;Olivier F. Bertrand.
The New England Journal of Medicine (2019)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
Jean-Claude Tardif;Jean Grégoire;Philippe L. L’Allier;Reda Ibrahim.
Structure, diversity and evolution of protein toxins from spore-forming entomopathogenic bacteria
Ruud A. de Maagd;Alejandra Bravo;Colin Berry;Neil Crickmore.
Annual Review of Genetics (2003)
Bacillus thuringiensis Toxins: An Overview of Their Biocidal Activity
Leopoldo Palma;Delia Muñoz;Colin Berry;Jesús Murillo.
Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
Scot-Heart Investigators;David E Newby;Philip D Adamson;Colin Berry.
The New England Journal of Medicine (2018)
Economics of chronic heart failure.
Colin Berry;David R. Murdoch;John J.V. McMurray.
European Journal of Heart Failure (2001)
Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.
Colin Berry;Carlene A. Hamilton;M. Julia Brosnan;Fergus G. Magill.
Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets
Graham H. Coombs;Daniel E. Goldberg;Michael Klemba;Colin Berry.
Trends in Parasitology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: